Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment
Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment
Active, not recruiting · NCT04169841 · Registry updated 2024-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment | Immunotherapy | Active, not recruiting | Phase 2 | 2024-02-13 | NCT04169841 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Centre Georges Francois Leclerc | 28 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Georges François Leclerc | Dijon | France | 15 |
| Centre Leon Berard | Lyon | France | 34 |
| Centre Oscar Lambret | Lille | France | 61 |
| CHRU Jean Minjoz | Besançon | France | 11 |
| CHU Amiens | Amiens | France | 49 |
| CHU François Mitterrand | Dijon | France | 2 |
| Institut Bergonié | Bordeaux | France | 47 |
| Institut Hospitalier Franco-Britannique | Levallois-Perret | France | 7 |